<div>
  <ul>
    <li>
      <p>
        Alife Health, an AI technology company for IVF, has partnered with US Fertility, the largest network of physician-owned fertility practices, to enhance IVF laboratory operations and provide patients with greater insight into their embryology processes through the integration of Alife's AI-powered Embryo Assist software.
      </p>
    </li>
    <li>
      <p>
        The partnership will implement Alife's Embryo Assist software, which integrates with laboratory microscopes to capture embryo images and data, enabling enhanced quality control measures and real-time lab updates. US Fertility, which performs over 50,000 IVF retrieval cycles annually across 200 physicians nationwide, aims to improve laboratory operations and provide patients with better insights into their IVF process.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/alife-health-partners-with-us-fertility-to-pilot-embryology-laboratory-ai-tools-302307315.html">
      Press release
    </a>
  </p>
</div>


Fertility Tech

PROMINENT_CATEGORY

<div>
  <p>Alife Health, an AI technology firm specializing in IVF, has entered into a partnership with US Fertility, a leading network of physician-owned fertility practices. The collaboration aims to bolster IVF laboratory procedures and afford patients deepened understanding of their embryology processes, thanks to Alife's AI-driven Embryo Assist software.</p>
  
 <p>The Embryo Assist software by Alife, interoperable with laboratory microscopes, facilitates the capturing of embryo pictures and related data thus bolstering quality control and enabling real-time laboratory updates. US Fertility, which carries out in excess of 50,000 IVF retrieval cycles yearly by 200 physicians all over the nation, aims to optimize laboratory procedures and offer patients an enhanced understanding of their IVF journey.</p>
  
</div>

Alife Health collaborates with US Fertility to enhance AI-powered IVF laboratory tools

ANALYST_QUICK_TAKE

INCUMBENTS_PRESENT

<div>
 
 <p>Smart ring manufacturer ŌURA has secured a Series D funding of USD 75 million from glucose monitoring device company Dexcom. The current investment values ŌURA at a total of USD 5 billion and raises the total funds received by the company to USD 223.3 million.</p>
 <p>The use of the funds by ŌURA has not been disclosed yet. However, a strategic partnership has been formed between the two companies to amalgamate their devices and apps. The first app integration is planned to be launched in the first half of 2025. The companies have also planned to collaborate on co-marketing and cross-selling initiatives.</p>
 <p>ŌURA has sold 2.5 million rings till date and predicts to double its annual sales to around USD 500 million in 2024. A 97% of the total members of the company express the desire to understand the impact of food on their health.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> <a href="https:<br>
//sp-edge.com/updates/35536"> Last month </a> , ŌURA acquired Sparta Science, a Bay Area-based health-tracking startup that offers a data platform to analyze health and performance information, for an undisclosed sum. With this investment and partnership, the company appears to be growing rapidly. This might be an attempt to counter the threats from larger entrants to the smart ring market, such as Samsung.</p>

ŌURA raises USD 75 million in Series D funding from Dexcom; secures partnership to integrate into devices and apps

<div>
 
 <p>Smartring manufacturer, Ōura, has bought Sparta Science, a health tracking startup from the Bay Area that offers a data platform for health and performance analysis, for an undisclosed amount.</p>
 <p>Sparta Science's main product is the Trinsic platform that tracks health vitals for corporate clients and enables organizations to amass and scrutinize health and performance data.</p>
 <p>Ōura intends to incorporate Sparta's Trinsic platform into its B2B product, Ōura Teams, through this purchase. This will allow business partners to merge Ōura ring data with data from other sources, offer insights on fitness and safety metrics, and design customized dashboards for healthcare and government clients.</p> 
 
</div> <p><b>Analyst Quicktake:<br>
 </b> This marks the second acquisition Ōura has carried out in 2024. In <a href="https:<br>
//sp-edge.com/updates/33488"> September </a> , the company acquired Veri, a Finnish personalized metabolic health company, for an undisclosed amount. The company noted that the acquisition of Veri was carried out to integrate Veri's expertise, expanding Ōura’s offerings in metabolic health. With its acquisition of Sparta Science, Ōura is further expanding its offerings to maintain its market position against competitors such as Samsung and Happy Health.</p>

Ōura acquires health tracking startup Sparta Science for undisclosed sum

<div>
 
 <p>Finland's Ōura Health has released the Ring 4, their latest smart ring. Replacing the earlier Ring 3, the new model is priced at USD 349 and offers enhanced health tracking accuracy.</p>
 <p>Enjoying twice the sensor count of its predecessor, the Ring 4 employs advanced algorithms tailored to user physiology and displays a sleek, titanium design with inset sensors. The ring offers improved precision in measuring blood oxygen levels and heart rate, especially during sleep.</p>
 <p>An independent study reveals that the Ring 4 provides a 30% improvement in data accuracy relating to blood oxygen, fills in significant gaps in heart rate data, and offers a 15% improvement in the precision of its breathing disturbance index. In addition to these improvements, the new model offers extended battery life, lasting up to eight days on a single charge.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> In <a href="https:<br>
//sp-edge.com/updates/33488"> September 2024 </a> , Ōura Health acquired metabolic health company Veri for an undisclosed sum. Through the acquisition, it planned to incorporate Veri's expertise to expand its offerings in metabolic health.</p>

Ōura launches Ring 4 with improved health tracking accuracy

<div>
 
 <p>Health technology company Ōura has acquired Veri, a Finnish metabolic health company. Veri's team, including its co-founders, will now become part of Ōura. Veri's innovative approach includes an app that guides users to the most beneficial foods and habits based on continuous glucose monitors (CGM). The app helps users understand the influence of nutrition on health, supporting efforts to lose weight, boost energy, and improve sleep.</p>
 <p>Planning to utilize Veri's know-how, Ōura aims to expand its metabolic health services, a field of significant interest to Ōura users. The company is set to introduce a new Meals feature this fall, designed to help users track meal timing and understand the impact of their eating habits on health indicators such as sleep, stress, and recovery.</p>
 
</div> <p><b>Analyst QuickTake</b> :<br>
 Traditionally, Ōura has tried to maintain its market share by <a href="https:<br>
//sp-edge.com/updates/30034"> suing potential new entrants </a> . However, this strategy fell apart when Samsung countered Ōura’s strategy by <a href="https:<br>
//sp-edge.com/updates/30034"> preemptively suing </a> the company before launching its Galaxy Ring. Now, it appears that Ōura is attempting to maintain its market presence by expanding its product features, as it plans to integrate Veri’s CGM functions into its wearable. The latest version of the ring, which could incorporate these features, is <a href="https:<br>
//techcrunch.com/2024/09/11/oura-has-acquired-metabolic-heath-startup-veri/"> rumored to be released soon </a> .</p>

Ōura acquires metabolic health company Veri for undisclosed sum

<div>
 
 <p>Irish health tech firm LetsGetChecked has acquired Truepill, an online pharmacy based in California, for a total of USD 525 million. The acquisition breakdown includes USD 25 million in cash, potential earnouts amounting to USD 200 million, and USD 150 million via a convertible note offering. The merger is projected to give rise to a digital pharmacy that markets and delivers LetsGetChecked's at-home testing kits.</p>
 <p>Despite both companies grappling with financial difficulties, with Truepill reporting a loss of USD 15 million following USD 64 million in revenues in the initial four months of this year, and LetsGetChecked recording a loss of USD 32 million after making USD 39 million in revenues within the first five months of 2023, the merger intends to consolidate both businesses under one entity. The company will continue trading under the Truepill name.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> In <a href="https:<br>
//sp-edge.com/updates/17522"> April 2023 </a> , Truepill sold off its UK-based operations to UK-based virtual pharmacy provider Phlo for an undisclosed sum. With its sale of the remainder of its operations to LetsGetChecked, Truepill appears to have handed over its operations and brand name to LetsGetChecked.</p>

LetsGetChecked acquires Truepill for USD 525 million

<div>
 
 <p>Bloomberg reports that Kindbody, a fertility services provider, is looking to secure between USD 30 million and USD 50 million in a new funding round. This round could reportedly decrease the company's pre-money valuation to USD 600 million from USD 1.8 billion previously. </p>
 <p>The funding round is expected to complete by mid-September with a new 'blue-chip growth equity investor' planning to invest at least USD 10 million and setting the terms of the round.</p>
 <p>Kindbody has faced recent challenges such as larger operational losses than anticipated, lower service use by clientele companies' employees, cost-cutting measures leading to clinic closures, and doctor turnover. </p> 
  
</div>

Kindbody seeks USD 30 million in funding to recapitalize

<div>
 <p>Menstrual health app Clue and mental health platform Headspace are collaborating to provide mental health support for cycle-related issues. The partnership will integrate Clue's cycle-tracking insights with Headspace's mental health resources to support users in managing stress associated with their menstrual cycle and different life stages.</p>
 <p>Clue Plus members will benefit from a 50% discount on Headspace subscriptions as part of the collaboration. The partnership is aimed at addressing the link between menstrual and mental health, offering targeted support for various cycle stages such as general tracking, fertility, pregnancy, and perimenopause/menopause.</p>
 <p>Data from Clue users indicate high rates of anxiety and depression, with 62% reporting difficulties managing daily life during menstrual symptoms and 75% expressing concerns about emotional symptoms. This initiative is a response to these challenges.</p>
 
</div>

Clue partners with Headspace to offer mental health support for menstrual cycle management

<div>
 
 <p>Fertilitywise has partnered with Fairfax EggBank, a leading repository of superior-quality frozen donor eggs in the US.</p>
 <p>This collaboration grants Fairfax EggBank's patients and clients a free two-month Fertilitywise membership, effectively shielding them from misinformation often spread on social media and offering them precise details and supportive assistance.</p>
 <p>As a comprehensive solution for fertility patients, Fertilitywise offers access to a comprehensive library of content that explains the science and research behind fertility treatments. Membership grants access to a professionally moderated private community, a secure environment for peer support. Currently, Fertilitywise memberships are available at a monthly rate of USD 19.99.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> In <a href="https:<br>
//femtechinsider.com/fertilitywise-launch/"> February 2024 </a> , Fertilitywise introduced an online membership program to provide resources and a supportive community for individuals and couples facing fertility challenges. The program offers educational articles and moderated discussion boards to assist those undergoing fertility treatments.</p>

Fertilitywise partners with Fairfax EggBank to enhance resources for fertility patients

<div>

 <p>Flo Health has successfully raised over USD 200 million in a Series C funding round, led by General Atlantic. This has boosted the company's valuation to over USD 1 billion.</p>
 <p>The investment will be used to support Flo's growth strategies, which include expanding its services to new user segments such as perimenopause and menopause. The company plans to integrate more tech-driven health updates and explore strategic expansion plans. Part of the funds will also be allotted for increasing the research and development team.</p>
 <p>As of June 2024, Flo Health has nearly 70 million active users monthly and about 5 million paid subscribers. The company's growth is also reflected in its gross bookings for 2024, which are expected to exceed USD 200 million, representing a 50% increase year-over-year.</p>

</div>

All Updates

Alife Health collaborates with US Fertility to enhance AI-powered IVF laboratory tools

ŌURA raises USD 75 million in Series D funding from Dexcom; secures partnership to integrate into devices and apps

Ōura acquires health tracking startup Sparta Science for undisclosed sum

Ōura launches Ring 4 with improved health tracking accuracy

Ōura acquires metabolic health company Veri for undisclosed sum

LetsGetChecked acquires Truepill for USD 525 million

Kindbody seeks USD 30 million in funding to recapitalize

Clue partners with Headspace to offer mental health support for menstrual cycle management

Fertilitywise partners with Fairfax EggBank to enhance resources for fertility patients

Flo Health raises ~USD 200 million in Series C funding to support growth plans

Fertility Tech

Alife Health collaborates with US Fertility to enhance AI-powered IVF laboratory tools

Contact us